Skip to main content
. 2021 Dec 26;23(1):231. doi: 10.3390/ijms23010231
AAZ acetazolamide
Absorp. absorption
ADMET absorption, distribution, metabolism, excretion, and toxicity
AMP ampicillin
BHI brain hearth infusion
BRZ brinzolamide
CA carbonic anhydrase
cat. catalyst
CLSI Clinical and Laboratory Standards Institute
CNS central neural system
Comp. compound
DCP dichlorphenamide
DMEM Dulbecco’s modified Eagle medium
DMF N,N-dimethylformamide
DMSO dimethyl sulfoxide
DOX doxorubicin
DZA dorzolamide
E. faecalis Enterococcus faecalis
E. faecium Enterococcus faecium
EMA European Medicines Agency
EZA ethoxzolamide
FDA Food and Drug Administration
FTIR Fourier transform infrared spectroscopy
hCA human carbonic anhydrase
HERG human ether-a-go-go-related gene
IFD induced-fit docking
IND indisulam
MD molecular dynamic
MIC minimum inhibitory concentration
MM/GBSA molecular mechanics generalized Born surface area
MRSA methicillin-resistant S. aureus
MTT methylthiazolyldiphenyl-tetrazolium bromide
MZA methazolamide
NMR nuclear magnetic resonance
NT not tested
PBC periodic boundary conditions
PBS phosphate buffered saline
PDB protein data bank
PME particle mesh Ewald
RMSD root mean square deviation
S. aureus Staphylococcus aureus
sp. species
supp. supported
TLC thin-layer chromatography
TMS tetramethylsilane
TOX toxicity
VAN vancomycin
VMD visual molecular dynamics
VRE vancomycin-resistant enterococci
WHO World Health Organization